All In MedTech

Device Trial Radar · NCT06230393

An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

An Extension Trial to Evaluate the Long Term Safety and Effectiveness of the STREAMLINE® SURGICAL SYSTEM in Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

17

Actual

Start

Jun 1, 2024

Primary completion

Dec 4, 2025

Study completion Dec 4, 2025

Sponsor

Lead sponsor
New World Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 30, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM

Conditions

  • Open Angle Glaucoma
  • Intraocular Pressure

Interventions

  • STREAMLINE® SURGICAL SYSTEMDevice

    STREAMLINE® SURGICAL SYSTEM

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in IOPTime frame: 24months; 36 months; 48months, 60 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinica 20/20

    San José, Costa Rica

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.